The Canadian journal of cardiology
-
The National Cholesterol Education Program Adult Treatment Panel (ATP) III recommendations incorporate new evidence for treating elevated low-density lipoprotein cholesterol. ⋯ A 10% reduction in overweight and obesity prevalence could have prevented 69,530 cases of drug eligibility in 2001. On the other hand, by 2011 over one million Canadians will be drug-eligible because of an elevated body mass index, if the recent trends in overweight and obese status continue.